Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Blood Screening Market Growth From $3.84 Billion In 2026 To $5.93 Billion By 2030 At A CAGR Of 11.5%
The blood screening market has experienced substantial expansion lately. Projections indicate a rise from $3.44 billion in 2025 to $3.84 billion in 2026, reflecting a compound annual growth rate of 11.6%. Factors contributing to this past growth include more stringent regulatory screening mandates, an increase in blood donation quantities, a higher incidence of transfusion-transmitted infections, the proliferation of centralized blood banking facilities, and the widespread implementation of ELISA testing methods.
The global blood screening market is poised for significant expansion, projecting to reach $5.93 billion by 2030 with a compound annual growth rate of 11.5%. This upward trajectory is primarily fueled by escalating investments in sophisticated screening technologies, a heightened need for prompt and precise diagnostic solutions, broader acceptance of molecular testing methodologies, the increasing incorporation of AI for data analytics, and a stronger emphasis on international blood safety protocols. Key developments anticipated during this period involve a greater uptake of nucleic acid testing, a surge in demand for high-volume screening systems, more widespread utilization of automated blood screening equipment, the proliferation of screening platforms integrated with software, and an intensified concentration on ensuring transfusion safety.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9047&type=smp
Blood Screening Market Opportunity Drivers: What Is Creating New Revenue Potential?
The escalating incidence of long-term health conditions is anticipated to be a significant catalyst for the expansion of the blood screening sector. Chronic illnesses, characterized as persistent ailments that are generally treatable rather than curable, necessitate ongoing management of both medical interventions and the lifestyle adjustments they demand. Blood screening plays a crucial role in ensuring donor-recipient blood type compatibility during transfusions, a procedure often essential for managing various chronic conditions such as autoimmune disorders, blood-related diseases, and all types of cancer. Globally, the World Health Organization reported in September 2023 that non-communicable diseases, or chronic conditions, account for a substantial 74% of the 41 million annual deaths worldwide. Consequently, this rising burden of chronic diseases is directly contributing to the advancement of the blood screening market.
Blood Screening Market Segmentation And Category Breakdown
The blood screening market covered in this report is segmented –
1) By Product: Reagents And Kits, Instruments, Software And Services
2) By Technology: Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blot Assays, Next-Generation Sequencing (NGS)
3) By End User: Blood Banks, Diagnostic Centers And Pathology Labs, Hospitals, Clinics, Ambulatory Surgical Centers (ASCs)
Subsegments:
1) By Reagents And Kits: Diagnostic Reagents, Testing Kits
2) By Instruments: Automated Analyzers, Manual Testing Equipment
3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Support And Consulting Services
Blood Screening Market Innovation Trends Driving Future Development
In the blood screening market, leading corporations are advancing techniques like liquid biopsy, aiming to refine early cancer identification, enhance treatment oversight, and facilitate customized medical treatments. Liquid biopsy represents a low-impact examination, scrutinizing blood or alternative bodily fluids for the presence of cancerous cells or tumor-derived genetic material. Illustratively, a notable development occurred in November 2023 when Guardant Health, Inc., a biotechnology firm situated in the United States, introduced its Shield blood-based screening assays. This Shield test is designed to examine cell-free DNA (cfDNA) circulating within the bloodstream, a marker that can signal the existence of colon tumors or precancerous lesions, by specifically identifying modifications in DNA fragments originating from malignant cells and subsequently released into the blood.
Blood Screening Market Competitive Analysis Of Major Industry Participants
Major companies operating in the blood screening market are Abbott Laboratories, Grifols S.A., Becton Dickinson and Company, F. Hoffmann-La Roche AG, bioMérieux S.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics Inc., Beckman Coulter Inc., Siemens Healthineers AG, DiaSorin S.p.A., Merck KGaA, PerkinElmer Inc., Bio-Techne Corporation, Roche Diagnostics GmbH, Danaher Corporation, Sysmex Corporation, GenMark Diagnostics Inc., QIAGEN N.V., Hologic Inc., Luminex Corporation, Trinity Biotech plc, Fujirebio Inc., OraSure Technologies Inc., Immunetics Inc., Cepheid Inc., Haemonetics Corporation, Verax Biomedical Inc.
Access The Complete Blood Screening Market Report:
https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report
#Blood Screening Market Largest Region: Which Geography Holds The Highest Market Share?
North Americawas the largest region in the blood screening market in 2025. The regions covered in the blood screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
